These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26342921)

  • 1. Antibiotic Discontinuation Rates Associated with Positive Respiratory Viral Panel and Low Procalcitonin Results in Proven or Suspected Respiratory Infections.
    Timbrook T; Maxam M; Bosso J
    Infect Dis Ther; 2015 Sep; 4(3):297-306. PubMed ID: 26342921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
    Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
    J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining Procalcitonin and Rapid Multiplex Respiratory Virus Testing for Antibiotic Stewardship in Older Adult Patients With Severe Acute Respiratory Infection.
    Lee CC; Chang JC; Mao XW; Hsu WT; Chen SY; Chen YC; How CK
    J Am Med Dir Assoc; 2020 Jan; 21(1):62-67. PubMed ID: 31791902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of the respiratory viral panel as an antimicrobial stewardship tool.
    Covert K; Bashore E; Edds M; Lewis PO
    J Clin Pharm Ther; 2021 Apr; 46(2):277-285. PubMed ID: 33277930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Procalcitonin and a Respiratory Polymerase Chain Reaction Panel to Reduce Antibiotic Use via an Electronic Medical Record Alert.
    Moradi T; Bennett N; Shemanski S; Kennedy K; Schlachter A; Boyd S
    Clin Infect Dis; 2020 Oct; 71(7):1684-1689. PubMed ID: 31637442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin-Guided Antibiotic Discontinuation Might Shorten the Duration of Antibiotic Treatment Without Increasing Pneumonia Recurrence.
    Akagi T; Nagata N; Wakamatsu K; Harada T; Miyazaki H; Takeda S; Ushijima S; Aoyama T; Yoshida Y; Yatsugi H; Wada K; Ueda Y; Fujita M; Watanabe K
    Am J Med Sci; 2019 Jul; 358(1):33-44. PubMed ID: 31084909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature.
    Covington EW; Roberts MZ; Dong J
    Pharmacotherapy; 2018 May; 38(5):569-581. PubMed ID: 29604109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Application of a Procalcitonin Monitoring Protocol in a Pediatric Intensive Care Unit.
    Wagner ME; Hale CM; Ericson JE; Trout LC
    J Pediatr Pharmacol Ther; 2021; 26(6):603-607. PubMed ID: 34421410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic practice patterns with procalcitonin levels in patients with acute lower respiratory tract infection.
    Costales-Cantrell JK; Chung J; Nomura JH; Ironside KR; Salama PW; Sim JJ
    Am J Manag Care; 2022 Feb; 28(2):e35-e41. PubMed ID: 35139294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to: implement procalcitonin testing in my practice.
    Neeser O; Branche A; Mueller B; Schuetz P
    Clin Microbiol Infect; 2019 Oct; 25(10):1226-1230. PubMed ID: 30616016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin to guide antibiotic decision making.
    Branche A; Neeser O; Mueller B; Schuetz P
    Curr Opin Infect Dis; 2019 Apr; 32(2):130-135. PubMed ID: 30648993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Process analysis of procalcitonin monitoring within community hospitals.
    Peña K; Cooper M; Greer N; Elders T; Septimus E
    Am J Health Syst Pharm; 2020 Apr; 77(8):632-635. PubMed ID: 32236452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of procalcitonin on antimicrobial treatment decisions in patients with coronavirus disease 2019 (COVID-19).
    Conlon ASC; Chopra Z; Cahalan S; Cinti S; Rao K
    Infect Control Hosp Epidemiol; 2023 Aug; 44(8):1314-1320. PubMed ID: 36330692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis.
    Ni W; Bao J; Yang D; Xi W; Wang K; Xu Y; Zhang R; Gao Z
    Infect Dis (Lond); 2019 Sep; 51(9):639-650. PubMed ID: 31355690
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical pulmonary infection score and a spot serum procalcitonin level to guide discontinuation of antibiotics in ventilator-associated pneumonia: a study in a single institution with high prevalence of nonfermentative gram-negative bacilli infection.
    Wongsurakiat P; Tulatamakit S
    Ther Adv Respir Dis; 2018; 12():1753466618760134. PubMed ID: 29506460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Collaborative Approach to Improve Consistent Use of Procalcitonin in Lower Respiratory Tract Infections.
    Levine AR; Riggott R; Vulaj K; Falcetti TR; Ali S; Singh G
    Ann Pharmacother; 2018 Jun; 52(6):538-545. PubMed ID: 29322872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Procalcitonin Monitoring on Duration of Antibiotics in Patients With Sepsis and/or Pneumonia in a Community Hospital Setting.
    Covington EW; Eure S; Carroll D; Freeman C
    J Pharm Technol; 2018 Jun; 34(3):109-116. PubMed ID: 34861025
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of the effects of procalcitonin testing on antimicrobial prescribing in respiratory tract infections in an Irish university hospital setting: a feasibility study.
    O'Riordan F; Shiely F; Byrne S; O'Brien D; Palmer B; Dahly D; O'Connor TM; Curran D; Fleming A
    J Antimicrob Chemother; 2019 Nov; 74(11):3352-3361. PubMed ID: 31325313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.